B. Braun Medical, Inc.; Withdrawal of Approval of Three New Drug Applications and One Abbreviated New Drug Application; Correction

---
identifier: "/us/fr/2017-18813"
source: "fr"
legal_status: "authoritative_unofficial"
title: "B. Braun Medical, Inc.; Withdrawal of Approval of Three New Drug Applications and One Abbreviated New Drug Application; Correction"
title_number: 0
title_name: "Federal Register"
section_number: "2017-18813"
section_name: "B. Braun Medical, Inc.; Withdrawal of Approval of Three New Drug Applications and One Abbreviated New Drug Application; Correction"
positive_law: false
currency: "2017-09-06"
last_updated: "2017-09-06"
format_version: "1.1.0"
generator: "[email protected]"
agency: "Health and Human Services Department"
document_number: "2017-18813"
document_type: "notice"
publication_date: "2017-09-06"
agencies:
  - "Health and Human Services Department"
  - "Food and Drug Administration"
fr_citation: "82 FR 42098"
fr_volume: 82
docket_ids:
  - "Docket No. FDA-2017-N-4642"
fr_action: "Notice; correction."
---


#  B. Braun Medical, Inc.; Withdrawal of Approval of Three New Drug Applications and One Abbreviated New Drug Application; Correction

**AGENCY:**

Food and Drug Administration, HHS.

**ACTION:**

Notice; correction.

**SUMMARY:**

The Food and Drug Administration (FDA) is correcting a document entitled “B. Braun Medical, Inc.; Withdrawal of Approval of Three New Drug Applications and One Abbreviated New Drug Application” that appeared in the *Federal Register* of August 3, 2017 (82 FR 36150). The document was published with the incorrect docket number. This document corrects that error.

**FOR FURTHER INFORMATION CONTACT:**

Lisa Granger, Office of Policy, Food and Drug Administration, Bldg. 32, Rm. 3330, Silver Spring, MD 20993-0002, 301-796-9115.

**SUPPLEMENTARY INFORMATION:**

In the *Federal Register* of Thursday, August 3, 2017, in FR Doc. 2017-16377, on page 36150, the following correction is made:

1. On page 36150, in the second column, in the header of the document, “Docket No. FDA-2017-N-0002” is corrected to read “Docket No. FDA-2017-N-4642”.

Dated: August 28, 2017.

Anna K. Abram,

Deputy Commissioner for Policy, Planning, Legislation, and Analysis.